• Mount Sinai Develops AI Prediction Tool for Cancer Patient Response to ICI Therapy

    Bio-IT World | Researchers at the Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSKCC), have developed SCORPIO, an artificial intelligence (AI) tool that can predict how well patients with cancer will respond to immune checkpoint inhibitor (ICI) therapy by analyzing routine blood tests and clinical data.

    Jan 22, 2025

  • PacBio at JPM: Portfolio Development, LDTs

    Bio-IT World | PacBio’s president Christian Henry gave the sequencing company’s 43rd Annual J.P. Morgan Healthcare Conference address last week. And while Oxford Nanopore and Illumina both doubled down on proteomics and a multi-omic future, Henry stayed focus on PacBio’s mission to enable the promise of genomics to better human health.

    Jan 21, 2025

  • Illumina at JPM: Multi-Omics, Constellation, Partnerships

    Bio-IT World | Jacob Thaysen gave Illumina’s annual presentation at the 43rd Annual J.P. Morgan Healthcare Conference yesterday, outlining Illumina’s early 2024 results and the vision for the future. Illumina is not focusing only on building sequencers and sequencing genomes. Thaysen outlined an M&A and partnership strategy focused on expanding the company’s addressable markets.

    Jan 16, 2025

  • Oxford Nanopore at JPM: A Proteomics-Genomics Thing of Beauty

    Bio-IT World | Gordon Sanghera, CEO, presented on behalf of Oxford Nanopore Technologies at the 43rd Annual J.P. Morgan Healthcare Conference this week in San Francisco. Sanghera led the major sequencing companies in position on the program, presenting on Monday a multi-omics and proteomics emphasis that was echoed throughout the week by other sequencing platform providers.

    Jan 15, 2025

  • Exploring Muscle Clues in Chronic Fatigue Syndrome and Long COVID

    Bio-IT World | An international team of researchers is delving into the molecular and cellular changes in muscle tissue associated with Chronic Fatigue Syndrome (CFS) and long COVID. The effort focuses on identifying biomarkers and pathways that could pave the way for diagnosis and treatment.

    Jan 14, 2025

  • Illumina Joins NVIDIA’s Agentic AI Vision at J.P. Morgan Healthcare Conference

    Bio-IT World | Among the many partnerships and technical announcements made by NVIDIA during the company's Monday morning presentation at the 43rd Annual J.P. Morgan Healthcare Conference, NVIDIA focused several on innovation within the healthcare and life sciences industry.

    Jan 13, 2025

  • Many Looming Unknowns About AI Policies of Incoming Administration

    Bio-IT World | Looming uncertainties tied to the upcoming U.S. administration change will affect many key areas of artificial intelligence (AI) in 2025, according to Mark Dredze, interim deputy director for the Data Science and AI Institute at Johns Hopkins University. While a focus on deregulation appears likely, exactly how things will play out for AI governance and policy is anyone’s guess.

    Jan 9, 2025

  • Medicines for Placental Disorders Working Their Way up the Species Ladder

    Bio-IT World | The placenta is a temporary but critical organ everyone needs to initiate their life, yet it remains one of the most understudied organs in human biology despite the possible lifelong health implications if anything it is supposed to do goes awry.

    Jan 8, 2025

  • Trendspotting: Predictions for Bio-IT World in 2025

    Bio-IT World | 2024 was full of innovative ideas and achievements. We spoke with industry experts and leaders about what to anticipate in the new year. Here are the full trends and predictions, including more on AI/ML, multimodal data, drug discovery, new policies, spatial biology, and more.

    Jan 7, 2025

  • Top Stories of 2024: Illumina, Pistoia Alliance, Generative AI, Sequencing, More

    Bio-IT World | Last year, the world of biotech achieved much with AI, sequencing, treatment development, and more. The Trends from the Trenches podcast also covered data management strategies, embracing change, and the technologies driving data-intensive science. To kick off the new year, here are the top stories and top podcast episodes of 2024 from Bio-IT World and Trends from the Trenches.

    Jan 3, 2025

  • AI Can’t Fix Bad Data: Why Semantic Technologies Are Key to R&D Acceleration

    Bio-IT World | What role will AI play in the future of drug development, especially as novel therapeutic approaches such as precision medicine drive up the complexity and cost of research? Some industry headlines hype AI as a magic bullet, capable of cutting through the headwinds of slow development cycles, shifting regulations, and high rates of failure. For companies racing to reach the market with safe and compliant new drug products, this vision of AI is compelling—and it’s driving heavy investment.

    Dec 30, 2024

  • BC Platform, University of Nottingham Partnership, Certis Oncology Launches AI Assistant, More

    Bio-IT World | BC Platforms enters an extended joint partnership with the University of Nottingham and Nottingham University Hospitals NHS Trust to provide data sharing platforms and tools; Certis Oncology Solutions launches CertisOI Assistant, an innovative chatbot tool ; and more.

    Dec 27, 2024

  • Follow the Money: Teaching AI Physics, AI-Powered Digital Twins of Cells, More

    Bio-IT World | AQEMIA intends to teach its generative AI platform quantum-inspired, atomic-scale physics to transform drug discovery; DeepLife plans to develop AI-powered models of human cells, known as digital twins of cells, for drug discovery; and more.

    Dec 23, 2024

  • Researchers Call for an Open AI Virtual Cell, Outline Challenges to Overcome

    Bio-IT World | In a Perspectives paper published last week in Cell, researchers from Stanford University, Genentech, and the Chan-Zuckerberg Initiative issued a call for AI to build a virtual cell. Technology is ripe for a biologically-valuable virtual cell, they say, outlining their views of the priorities and opportunities.

    Dec 18, 2024

  • Renee Iacona on Why Future Scientists Need to Learn About Data Science

    Bio-IT World | It has been a momentous year for artificial intelligence and machine learning. AI models can simulate clinical trials, diagnose diseases early, and detect biomarkers, and there is still no shortage of innovative ideas. However, there are some concerns surrounding AI/ML that have also been at the forefront of the industry. The latest episode of Trends from the Trenches covers one of these concerns.

    Dec 17, 2024

  • Ingredient in Children’s Glue Helps Tumors Retain Cancer Drug

    Bio-IT World | Japan has long taken a leadership role in the pursuit of boron neutron capture therapy (BNCT) as a treatment for cancer. The approach involves injecting patients with a boron-containing compound that accumulates in tumor cells and acts as an exclusive target for neutrons to kill and was the research focus of a pair of Harvard scientists throughout the 1950s.

    Dec 13, 2024

  • Some Gut Bacteria Can be Transmitted Through Close Social Contact

    Bio-IT World | An intriguing new study suggests that the people we interact with socially influence the bacteria populating our gut. The implication is that some diseases considered nontransmissible may have a component that makes them contagious.

    Dec 11, 2024

  • Russia Launches Comprehensive Study Genomes Of Living Organisms In Arctic Region

    Bio-IT World | A project to study the genomes of living organisms in the Arctic region, known as “A Thousand Arctic Genomes,” has been launched in Russia. As part of the project, scientists will create genetic data banks and perform whole-genome sequencing of Arctic inhabitants in order to assess biodiversity and use the data obtained to preserve it.

    Dec 10, 2024

  • ‘Therapeutic EVs’ in a Nasal Spray Could One Day Treat Alzheimer’s Disease

    Bio-IT World | It sounds too good to be true: a nasal spray that delays Alzheimer’s-related behavioral and cognitive problems a decade or more after initial diagnosis. But promising first steps in that direction have already been taken using “therapeutic EVs” (extracellular vesicles) restricting the activation of inflammatory cytokines in the brain of mice.

    Dec 5, 2024

  • Building Tiny Biocompatible Batteries with Heart-Defibrillating Power

    Bio-IT World | In a paper published last week in Science, researchers from the University of Oxford, UK, demonstrate how microprocessors can be created from soft, biocompatible, nanoliter-scale hydrogel droplets. This work builds on a study published last month in Nature Chemical Engineering introducing poppyseed-sized droplet batteries that can be used to power such systems for various bionic and biomedical applications.

    Dec 4, 2024